Perrigo (PRGO) Operating Expenses (2012 - 2026)
Perrigo (PRGO) posted quarterly Operating Expenses of $697.8 million for Q1 2026, up 102.03% year-over-year from $345.4 million in Q1 2025, and down 57.69% quarter-over-quarter from $1.6 billion in Q4 2025.
Perrigo (PRGO) Operating Expenses (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Operating Expenses for 15 consecutive years, with $697.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 102.03% year-over-year to $697.8 million; the TTM figure through Mar 2026 stood at $3.0 billion (up 117.95% YoY), while the FY2025 annual figure was $2.6 billion, up 83.01% from the prior year.
- Operating Expenses eased to $697.8 million in Q1 2026 per PRGO's latest filing, from $1.6 billion in the prior quarter.
- Across five years, Operating Expenses topped out at $1.6 billion in Q4 2025 and bottomed at $271.7 million in Q4 2024.
- Historically, Operating Expenses has averaged $450.0 million across 5 years, with a median of $351.6 million in 2022.
- Annual changes were most pronounced in 2024 — Operating Expenses plunged 38.65% — and 2025, when it jumped 507.03%.
- Perrigo's Operating Expenses stood at $351.6 million in 2022, then rose by 25.97% to $442.9 million in 2023, then slumped by 38.65% to $271.7 million in 2024, then surged by 507.03% to $1.6 billion in 2025, then slumped by 57.69% to $697.8 million in 2026.
- Business Quant data shows PRGO's Operating Expenses at $697.8 million in Q1 2026, $1.6 billion in Q4 2025, and $304.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | 290.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 290.50 Mn |
| Mar 28, 2026 | 697.80 Mn |
| Dec 31, 2025 | 1.65 Bn |
| Sep 27, 2025 | 304.50 Mn |
| Jun 28, 2025 | 317.50 Mn |
| Mar 29, 2025 | 345.40 Mn |
| Dec 31, 2024 | 271.70 Mn |
| Sep 28, 2024 | 324.00 Mn |
| Jun 29, 2024 | 421.20 Mn |
| Mar 30, 2024 | 412.90 Mn |
| Dec 31, 2023 | 442.90 Mn |
| Sep 30, 2023 | 349.10 Mn |
| Jul 1, 2023 | 371.20 Mn |
| Apr 1, 2023 | 365.30 Mn |
| Dec 31, 2022 | 351.60 Mn |
| Oct 1, 2022 | 329.80 Mn |
| Jul 2, 2022 | 379.00 Mn |
| Apr 2, 2022 | 316.10 Mn |
| Dec 31, 2021 | 315.70 Mn |
| Oct 2, 2021 | -101.90 Mn |